Articles Tagged With:
-
Are Procedural Complications Related to Sleep Pattern the Night Before?
Conducted in a 700+ bed tÿ -
Early Delivery: Neonatal Outcomes After Demonstrated Fetal Lung Maturity Before 39 Weeks of Gestation
The pendulum has been swinging away from doing early deliveries without indications, but the question remains: What is early? -
Rivaroxaban: A Fixed-dose Regimen for Anticoagulation
This paper presents two parallel studies that evaluate the safety and efficacy of oral rivaroxaban in the treatment of acute deep venous thrombosis (DVT) and in continuing prophylaxis for recurrence. -
OB/GYN Clinical Alert February 2011 Issue in PDF
-
Clinical Briefs in Primary Care supplement
-
Pharmacology Watch: Statin Use in Patients with Abnormal Liver Function
In this issue: Statins and liver function; dosing timing for thyroxine; rivaroxaban for VTE, DVT, and stroke; echinacea and the common cold; and FDA actions. -
Clinical Trials Administrator January 2011 Issue in PDF
-
2010 Salary Survey Results: It's performance and results — and not just the economy — impacting research sites
Clinical trial sites might be experiencing an upward or downward cycle of business, but they can't blame it on the economy, some experts say. -
International research requires lengthy capacity building
International HIV vaccine trials underway in resource-poor settings provide good examples of how clinical research (CR) can be done in both ethical and culturally-sensitive ways despite a wide variety of obstacles. -
Compliance Corner: Yale's QI self-assessment tool assists with better site compliance
Many clinical research institutions have limited resources for internal audits or quality improvement (QI) checks, so the key is to create proactive tools and policies to improve overall site regulatory compliance.